(PROJECT 1) The central hypothesis of this program grant is that endogenous DNA damage is a major contributor to the aging process via induction of DNA damage responses and their biological outcomes, such as altered activity of cellular processes, mutations and epigenetic changes, apoptosis and cellular senescence. Project 1 previously established several mouse models with defects in DNA repair, which have an accelerated aging phenotype. In the current grant, we demonstrated with Core B that dietary restriction (DR) enormously prolongs lifespan and health of accelerated aging mouse models. This is important, because this provide us a competitive edge to study the mechanism of DR in a 5-10 fold shorter timeframe. Within the context of this renewal application, we will focus in specific aim 1 on the underlying mechanisms of DR. In collaboration with Project 2 and 3 we will address the hypothesis whether DR acts by reducing the DNA damage load via improved DNA damage repair and signaling including its downstream consequences ((epi)mutations, cellular senescence, apoptosis) or via reduced generation or enhanced scavenging of endogenous reactive metabolites such as reactive oxygen species or advanced glycation endproducts. Furthermore, we will extensively delineate molecular and cellular changes in response to DR with the aim to identify novel therapeutic targets.
In specific aim 2, we will follow up on a recent discovery in which we identified a microRNA signature for aging across several wild type aged mouse organs, which is directly upregulated by transcription- blocking DNA lesions. One of the main functions of these microRNAs is to repress cell death and maintain cell viability in the presence of unrepaired DNA damage, a process we have designated 'cell preservation'. Strikingly, Project 4 has identified induction of many cell preservation microRNAs in extreme human longevity, suggesting that cell preservation is associated with healthy aging. In collaboration with project 2, 3, 4 and core B we will further study microRNA-based cell preservation by silencing these microRNAs in accelerated aging mice to determine a causal role in aging. In addition, we will study the molecular basis of cell preservation and determine associated cellular aging phenotypes such as inflammation, energy metabolism and mutation frequencies. The results from these specific aims will provide new insight into the role of DNA damage in aging and mechanisms underlying DR.

Public Health Relevance

(PROJECT 1) Aging and age-related diseases are one of the major challenges for health care in industrialized societies. Understanding the molecular and cellular basis of aging is a prerequisite for designing interventions. We have established a strong link between DNA damage and aging using accelerated aging mouse models, which will be employed for rapidly intervention screening and delineating the molecular basis of aging.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
2P01AG017242-17A1
Application #
8742952
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2014-09-30
Budget End
2015-04-30
Support Year
17
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Type
DUNS #
City
Bronx
State
NY
Country
United States
Zip Code
Lau, Cia-Hin; Suh, Yousin (2018) In vivo epigenome editing and transcriptional modulation using CRISPR technology. Transgenic Res 27:489-509
Wiley, Christopher D; Schaum, Nicholas; Alimirah, Fatouma et al. (2018) Small-molecule MDM2 antagonists attenuate the senescence-associated secretory phenotype. Sci Rep 8:2410
Quispe-Tintaya, Wilber; Lee, Moonsook; Dong, Xiao et al. (2018) Bleomycin-induced genome structural variations in normal, non-tumor cells. Sci Rep 8:16523
Hébert, Jean M; Vijg, Jan (2018) Cell Replacement to Reverse Brain Aging: Challenges, Pitfalls, and Opportunities. Trends Neurosci 41:267-279
Lau, Cia-Hin; Suh, Yousin (2017) In vivo genome editing in animals using AAV-CRISPR system: applications to translational research of human disease. F1000Res 6:2153
Hernandez-Segura, Alejandra; de Jong, Tristan V; Melov, Simon et al. (2017) Unmasking Transcriptional Heterogeneity in Senescent Cells. Curr Biol 27:2652-2660.e4
Wiley, Christopher D; Flynn, James M; Morrissey, Christapher et al. (2017) Analysis of individual cells identifies cell-to-cell variability following induction of cellular senescence. Aging Cell 16:1043-1050
Milholland, Brandon; Dong, Xiao; Zhang, Lei et al. (2017) Differences between germline and somatic mutation rates in humans and mice. Nat Commun 8:15183
Baar, Marjolein P; Brandt, Renata M C; Putavet, Diana A et al. (2017) Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging. Cell 169:132-147.e16
Milholland, Brandon; Suh, Yousin; Vijg, Jan (2017) Mutation and catastrophe in the aging genome. Exp Gerontol 94:34-40

Showing the most recent 10 out of 253 publications